Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

Research sheds new light on genetic, environmental factors that promote prostate cancer metastasis

Research sheds new light on genetic, environmental factors that promote prostate cancer metastasis

Prostate cancer’s gene-determined ‘immune landscape’ dictates tumor progression

Prostate cancer’s gene-determined ‘immune landscape’ dictates tumor progression

Novel polygenic hazard score captures age variations of aggressive prostate cancer

Novel polygenic hazard score captures age variations of aggressive prostate cancer

Computer model based on AI improves analysis of kidney biopsies

Computer model based on AI improves analysis of kidney biopsies

Clinical study investigates lifestyle biomarkers in prostate cancer survivors

Clinical study investigates lifestyle biomarkers in prostate cancer survivors

Men who follow Mediterranean diet have lower risk of aggressive prostate cancer, study finds

Men who follow Mediterranean diet have lower risk of aggressive prostate cancer, study finds

Stress accelerates development of pancreatic cancer, study shows

Stress accelerates development of pancreatic cancer, study shows

New blood stabilization method prolongs lifespan of blood samples for CTC profiling

New blood stabilization method prolongs lifespan of blood samples for CTC profiling

Cancer death rate continues decades-long drop in the United States

Cancer death rate continues decades-long drop in the United States

Rutgers researcher receives $1 million grant for international prostate cancer study

Rutgers researcher receives $1 million grant for international prostate cancer study

Blueberry extract can enhance effectiveness of cervical cancer treatment

Blueberry extract can enhance effectiveness of cervical cancer treatment

Researchers design electronic nose to sniff out colon diseases

Researchers design electronic nose to sniff out colon diseases

Nanobiotix receives FDA approval for first immuno-oncology trial

Nanobiotix receives FDA approval for first immuno-oncology trial

Researchers develop nanowire device to detect urinary markers implicated in cancer

Researchers develop nanowire device to detect urinary markers implicated in cancer

Proton therapy center for treating cancer patients coming to Utah

Proton therapy center for treating cancer patients coming to Utah

Study suggests new target to treat prostate cancer

Study suggests new target to treat prostate cancer

Medicaid expansion improves early-stage cancer detection, research shows

Medicaid expansion improves early-stage cancer detection, research shows

Doing more harm than good? Epidemic of screening burdens nation’s older patients

Doing more harm than good? Epidemic of screening burdens nation’s older patients

Spatial deconvolution of marker expression in whole heart subjected to ischemia-reperfusion

Spatial deconvolution of marker expression in whole heart subjected to ischemia-reperfusion

Prostate cancer researchers find significant disparities between two liquid biopsy providers

Prostate cancer researchers find significant disparities between two liquid biopsy providers